Trends in first‐line monotherapy and combination therapy for hypertension in UK primary care
First-line antihypertensive combination therapy remains exceedingly rare in the UK in accordance with National Institute for Health and Care Excellence guidelines, but in contrast to other international recommendations. Treatment persistence was lower on first-line combination therapy than monotherapy.
Authors
- James M. Brophy (ORCID: https://orcid.org/0000-0001-8049-6875)
- Christel Renoux (ORCID: https://orcid.org/0000-0002-4691-9579)
- Robert W. Platt (ORCID: https://orcid.org/0000-0002-5981-8443)
- Kyle Johnson (ORCID: https://orcid.org/0000-0002-4366-2392)
- Sarah Beradid (ORCID: https://orcid.org/0009-0008-6177-3759)
Institutions
- Jewish General Hospital (CA)
- McGill University (CA)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2025-09-13
- DOI
- https://doi.org/10.1002/bcp.70271
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00